Novo Nordisk’s CagriSema outperforms Ozempic in phase III study

Novo Nordisk’s CagriSema outperforms Ozempic in phase III study

Novo Nordisk’s CagriSema outperformed the company’s flagship type 2 diabetes drug Ozempic (semaglutide) in both HbA1c levels and weight loss in a phase III trial. In the REIMAGINE 2 study (NCT06065540), CagriSema achieved a superior reduction in HbA1c of 1.91% points compared to 1.76% points with Ozempic after 68 weeks. CagriSema also led to a … Read more

A common nutrient deficiency could increase the risk of Alzheimer’s, a new study says

A common nutrient deficiency could increase the risk of Alzheimer’s, a new study says

Reviewed by Dietitian Jessica Ball, MS, RD Design elements: Getty Images. Design EatingWell. Key points Choline is an essential micronutrient for a healthy brain and nervous system. Low levels of choline in the blood are linked to a higher risk of Alzheimer’s disease. Choline is found in seafood, meat, dairy, nuts, potatoes, legumes and whole … Read more